Production (Stage)
Alto Neuroscience, Inc.
ANRO
$3.03
$0.103.41%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 160.75M | 168.23M | 181.70M | 193.12M | 205.90M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.75M | 1.08M | 1.55M | 2.14M | 2.27M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 23.00K | 30.00K | 277.00K | 148.00K | 150.00K |
| Total Current Assets | 163.52M | 169.34M | 183.53M | 195.41M | 208.31M |
|
|
|||||
| Total Current Assets | 163.52M | 169.34M | 183.53M | 195.41M | 208.31M |
| Net Property, Plant & Equipment | 7.32M | 7.70M | 7.58M | 1.44M | 1.55M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.07M | 504.00K | 504.00K | 504.00K | 58.00K |
| Total Assets | 171.92M | 177.54M | 191.61M | 197.36M | 209.92M |
|
|
|||||
| Total Accounts Payable | 1.38M | 1.58M | 2.25M | 1.84M | 2.41M |
| Total Accrued Expenses | 4.97M | 7.56M | 7.52M | 5.68M | 4.07M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 876.00K | 870.00K | 4.25M | 2.32M | 1.20M |
| Total Finance Division Other Current Liabilities | 24.00K | -- | -- | -- | 320.00K |
| Total Other Current Liabilities | 24.00K | -- | -- | -- | 320.00K |
| Total Current Liabilities | 7.26M | 10.01M | 14.02M | 9.84M | 8.01M |
|
|
|||||
| Total Current Liabilities | 7.26M | 10.01M | 14.02M | 9.84M | 8.01M |
| Long-Term Debt | 21.15M | 11.56M | 6.63M | 7.74M | 8.81M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 4.41M | 4.52M | 4.62M | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 1.30M | -- | -- |
| Total Liabilities | 32.82M | 26.08M | 26.56M | 17.58M | 16.82M |
|
|
|||||
| Common Stock & APIC | 292.65M | 289.96M | 288.34M | 286.28M | 283.57M |
| Retained Earnings | -153.57M | -138.40M | -123.20M | -106.41M | -90.38M |
| Treasury Stock & Other | 14.00K | -101.00K | -95.00K | -89.00K | -84.00K |
| Total Common Equity | 139.10M | 151.46M | 165.05M | 179.78M | 193.10M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 139.10M | 151.46M | 165.05M | 179.78M | 193.10M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 139.10M | 151.46M | 165.05M | 179.78M | 193.10M |
|
|
|||||